RIVA-DM: Effectiveness and Safety of Rivaroxaban vs. Warfarin in Nonvalvular Atrial Fibrillation and Diabetes Mellitus: Analysis of Electronic Health Record DataFirst published 20/08/2020 Last updated 02/07/2024 EU PAS number: EUPAS36634StudyFinalised